Hangzhou Ruidi Biotechnology Ltd.
PrivateLast Round
Series B
Extension
Feb 11, 2025
Total Funding Raised
$48.1M
Company Overview
Hangzhou Ruidi Biotechnology Ltd. is a medical device company that develops nanosecond pulsed electric field (nsPEF) ablation systems for the treatment of solid tumors and other medical conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Ruidi Biotechnology Ltd. Comparables
Compare Hangzhou Ruidi Biotechnology Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pulsecare Medical | 85% | |
| Remedicine Co., Ltd. | 83% | |
| Galvanize Therapeutics | 78% |
Hangzhou Ruidi Biotechnology Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 11, 2025 | ||||
| Series B | Oct 17, 2021 | ||||
| Series A Extension | Oct 28, 2020 | ||||
| Series A | Feb 18, 2019 |
Hangzhou Ruidi Biotechnology Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Series B |
| Zhangjiang Shuifeng Innovation Equity Investment Fund | Series B Extension |
| Proxima Ventures Ltd. | Angel, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2025
$14M round with Zhangjiang Shuifeng Innovation and He Haichao.
- Feb 18, 2019
$3M round led by Proxima Ventures Ltd.
Hangzhou Ruidi Biotechnology Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hangzhou Ruidi Biotechnology Ltd.'s valuation, stock price, and market status.
Is Hangzhou Ruidi Biotechnology Ltd. a public or private company?
Hangzhou Ruidi Biotechnology Ltd. is a private company.
What is the current stock price of Hangzhou Ruidi Biotechnology Ltd.?
Hangzhou Ruidi Biotechnology Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Hangzhou Ruidi Biotechnology Ltd. worth (valuation)?
Valuation information for Hangzhou Ruidi Biotechnology Ltd. is not publicly available.
Can I buy Hangzhou Ruidi Biotechnology Ltd. stock?
Hangzhou Ruidi Biotechnology Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hangzhou Ruidi Biotechnology Ltd.'s last funding round?
Funding round information for Hangzhou Ruidi Biotechnology Ltd. is not publicly available.
Who are the main investors in Hangzhou Ruidi Biotechnology Ltd.?
Investor information for Hangzhou Ruidi Biotechnology Ltd. is not publicly disclosed.
Will Hangzhou Ruidi Biotechnology Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou Ruidi Biotechnology Ltd..
How can I track Hangzhou Ruidi Biotechnology Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hangzhou Ruidi Biotechnology Ltd.'s secondary market activity and sign up for updates.